Señales en vivo de EXPRS2.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 03:23):

ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark...

Stats
Volumen de hoy	8 627.00
Volumen promedio	150 126
Capitalización de mercado	79.37M
EPS	SEK-0.443 ( 2023-11-16 )
Próxima fecha de ganancias	( SEK0 ) 2024-05-30
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.580
ATR14	SEK0.0130 (0.81%)

Volumen Correlación

Largo: -0.24 (neutral)

Corto: 0.19 (neutral)

Signal:(67.993) Neutral

ExpreS2ion Biotech Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ExpreS2ion Biotech Correlación - Moneda/Commodity

-0.20
( neutral )

-0.05
( neutral )

0.00
( neutral )

-0.07
( neutral )

0.43
( neutral )

ExpreS2ion Biotech Finanzas

Annual	2023
Ingresos:	SEK8.80M
Beneficio Bruto:	SEK5.15M (58.55 %)
EPS:	SEK-2.08

FY	2023
Ingresos:	SEK8.80M
Beneficio Bruto:	SEK5.15M (58.55 %)
EPS:	SEK-2.08

FY	2022
Ingresos:	SEK5.09M
Beneficio Bruto:	SEK5 000.00 (0.10 %)
EPS:	SEK-3.14

FY	2021
Ingresos:	SEK12.23M
Beneficio Bruto:	SEK4.72M (38.59 %)
EPS:	SEK-1.336

Financial Reports:

No articles found.

ExpreS2ion Biotech

ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.